As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
With an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer’s disease, the road to a cure seems ...
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
Alpha Cognition and China Medical System sign a $44M licensing deal for Zunveyl. ALPHA-1062 preclinical data shows benefits ...
Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.
The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS ...
The drug was developed from methylene blue, a medicine previously used to treat malaria. Professor Alistair Burns, former NHS clinical director for dementia ... "After no new therapies for ...
Discover a groundbreaking study that may help detect Alzheimer's in its early stages. Learn about the link between blood molecules and cognitive symptoms.
Nov. 19, 2024 — Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new ... Earlier Diabetes Diagnosis Linked to Dementia Risk Nov. 19, 2024 ...
The study also integrates drug databases ... New Brain Mapping Technique Reveals ... connection between brain 'waste ... How Dementia Affects the Brain's Ability to Empathize Dec. 3, 2024 ...